Effects of genetic background on tumorigenesis in p53-deficient mice - PubMed (original) (raw)
Comparative Study
Effects of genetic background on tumorigenesis in p53-deficient mice
L A Donehower et al. Mol Carcinog. 1995 Sep.
Abstract
Mice with disrupted germline p53 alleles have been engineered by us and others and have been shown to have enhanced susceptibility to spontaneous tumors of various types. We monitored a large number of p53-deficient mice (p53+/- and p53-/-) and their wild-type littermates (p53+/+) of two different genetic backgrounds (129/Sv and mixed C57BL/6 x 129/Sv) up to 2 yr of age. p53+/- and p53-/- 129/Sv mice show accelerated tumorigenesis rates compared with their p53-deficient counterparts of mixed C57BL/6 x 129/Sv genetic background. The tumor spectra of the two strains of mice are similar except that almost half of 129/Sv p53-/- males develop malignant teratomas, whereas these tumors are rarely observed in C57BL/6 x 129/Sv mice and never in 129/Sv p53+/- males. In the study reported here, we further characterized the lymphomas that arose in the p53-nullizygous mice and found that over three-quarters of the lymphomas were of thymic origin and contained primarily immature (CD4+/CD8+) T-cells, whereas the remainder originated in the spleen and peripheral lymph nodes and were of B-cell type. The high incidence of early-onset lymphomas in the nullizygous mice makes these animals a good lymphoma model, whereas the heterozygous mice may be a useful model for Li-Fraumeni syndrome, a human inherited cancer predisposition.
Similar articles
- Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.
Kuperwasser C, Hurlbut GD, Kittrell FS, Dickinson ES, Laucirica R, Medina D, Naber SP, Jerry DJ. Kuperwasser C, et al. Am J Pathol. 2000 Dec;157(6):2151-9. doi: 10.1016/S0002-9440(10)64853-5. Am J Pathol. 2000. PMID: 11106587 Free PMC article. - Genetic background alters the spectrum of tumors that develop in p53-deficient mice.
Harvey M, McArthur MJ, Montgomery CA Jr, Bradley A, Donehower LA. Harvey M, et al. FASEB J. 1993 Jul;7(10):938-43. doi: 10.1096/fasebj.7.10.8344491. FASEB J. 1993. PMID: 8344491 - Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice.
Hulla JE, French JE, Dunnick JK. Hulla JE, et al. Carcinogenesis. 2001 Jan;22(1):89-98. doi: 10.1093/carcin/22.1.89. Carcinogenesis. 2001. PMID: 11159746 - The Evolution of Tumors in Mice and Humans with Germline p53 Mutations.
Levine AJ, Chan CS, Dudgeon C, Puzio-Kuter A, Hainaut P. Levine AJ, et al. Cold Spring Harb Symp Quant Biol. 2015;80:139-45. doi: 10.1101/sqb.2015.80.027631. Epub 2015 Dec 7. Cold Spring Harb Symp Quant Biol. 2015. PMID: 26642854 Review. - The p53-deficient mouse: a model for basic and applied cancer studies.
Donehower LA. Donehower LA. Semin Cancer Biol. 1996 Oct;7(5):269-78. doi: 10.1006/scbi.1996.0035. Semin Cancer Biol. 1996. PMID: 9110404 Review.
Cited by
- Comprehensive single cell aging atlas of mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and cancer.
Angarola BL, Sharma S, Katiyar N, Gu Kang H, Nehar-Belaid D, Park S, Gott R, Eryilmaz GN, LaBarge MA, Palucka K, Chuang JH, Korstanje R, Ucar D, Anczukow O. Angarola BL, et al. bioRxiv [Preprint]. 2023 Oct 23:2023.10.20.563147. doi: 10.1101/2023.10.20.563147. bioRxiv. 2023. PMID: 37961129 Free PMC article. Updated. Preprint. - Mammary tumor modifiers in BALB/cJ mice heterozygous for p53.
Koch JG, Gu X, Han Y, El-Naggar AK, Olson MV, Medina D, Jerry DJ, Blackburn AC, Peltz G, Amos CI, Lozano G. Koch JG, et al. Mamm Genome. 2007 May;18(5):300-9. doi: 10.1007/s00335-007-9028-2. Epub 2007 Jun 8. Mamm Genome. 2007. PMID: 17557176 - Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis.
Su T, Suzui M, Wang L, Lin CS, Xing WQ, Weinstein IB. Su T, et al. Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7824-9. doi: 10.1073/pnas.1332160100. Epub 2003 Jun 16. Proc Natl Acad Sci U S A. 2003. PMID: 12810953 Free PMC article. - DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies.
Schmidt WM, Uddin MH, Dysek S, Moser-Thier K, Pirker C, Höger H, Ambros IM, Ambros PF, Berger W, Bittner RE. Schmidt WM, et al. PLoS Genet. 2011 Apr;7(4):e1002042. doi: 10.1371/journal.pgen.1002042. Epub 2011 Apr 14. PLoS Genet. 2011. PMID: 21533183 Free PMC article. - Genetic modifiers regulating DNA replication and double-strand break repair are associated with differences in mammary tumors in mouse models of Li-Fraumeni syndrome.
Majhi PD, Griner NB, Mayfield JA, Compton S, Kane JJ, Baptiste TA, Dunphy KA, Roberts AL, Schneider SS, Savage EM, Patel D, Blackburn AC, Maurus KJ, Wiesmüller L, Jerry DJ. Majhi PD, et al. Oncogene. 2021 Aug;40(31):5026-5037. doi: 10.1038/s41388-021-01892-5. Epub 2021 Jun 28. Oncogene. 2021. PMID: 34183771 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous